Parvovirus B19 infection in the immunocompromised host

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 5, 2007, Pages 799-804

  Florea, Anca V ^a,c   Ionescu, Diana N ^b   Melhem, Mona F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ANEMIA; BONE MARROW CELL; CELLULAR IMMUNITY; CLINICAL FEATURE; DNA VIRUS; ERYTHROID PRECURSOR CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LABORATORY TEST; PARVOVIRUS; PARVOVIRUS INFECTION; REVIEW;

HUMANS; IMMUNOCOMPROMISED HOST; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 34248221597     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet. 1975;1(7898):72-73.
2. Freitas RB, Monteiro TA, Silva Filho MG, Linhares AC. Association between human parvovirus B19 and arthropathy in Belem, Para, North Brazil. Rev Inst Med Trop Sao Paulo. 2002;44:17-22.
3. Cacoub P, Boukli N, Hausfater P, et al. Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinemia. Ann Rheum Dis. 1998;57:422-424.
4. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:152-157.
5. Sant'Anna AL, Garcia Rde C, Marzoche M, et al. Study of chronic hemolytic anemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises. Rev Inst Med Trop Sao Paulo. 2002;44:187-190.
6. Kerr JR, Barah F, Mattey DL, et al. Circulating tumor necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol. 2001;82(pt 12):3011-3019.
7. Kerr JR, Barah F, Chiswick ML, et al. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry. 2002;73:739-746.
8. Heegaard ED, Myhre J, Hornsleth A, Gundestrup M, Boye H. Parvovirus B19 infections in patients with chronic anemia. Haematologica. 1997;82:402-405.
9. Aguiar FS, Lopes DP, Bazin AR, Setubal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop. 2001; 34:239-242.
10. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53(pt 6):459-475.
11. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994;330:1192-1196.
12. Frempong K. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood. 2004;103:422-427.
13. Heegaard ED, Petersen BL, Heilmann CJ, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol. 2002;40:933-936.
14. De Renzo A, Azzi A, Zakrzewska K, Cicoira L, Notaro R, Rotoli B. Cytopenia caused by parvovirus in an adult ALL patient. Hematologica. 1994;79:259-261.
15. Anderson LJ, Tsou C, Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986;24:522-526.
16. Ergas D, Resnitzky P, Berrebi A. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia. Blood. 1996; 87:3523-3524.
17. Koch WC, Adler SP. Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J Clin Microbiol. 1990;28:65-69.
18. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485-505.
19. Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000;11:1132-1137.
20. Kerr JR, Barah F, Cunniffe VS, et al. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukemia. J Clin Pathol. 2003;56:873-875.
21. Clarke J, Lee JD. Primary human parvovirus B19 infection in an HIV infected patient on highly active antiretroviral therapy. Sex Transm Infect. 2003;79: 336.
22. Musiani M, Roda A, Zerbini M, et al. Detection of parvovirus B19 DNA in bone marrow cells by chemiluminescence in situ hybridization. J Clin Microbiol. 1996;34:1313-1316.
23. Goedert JJ, Erdman DD, Konkle BA, et al. Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia. Am J Hematol. 1997;56:248-251.
24. Setubal S, Jorge-Pereira MC, de Sant'Anna AL, de Oliveira SA, Bazin AR, do Nascimento JP. Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS. Rev Soc Bras Med Trop. 2003;36:299-302.
25. Sabella C, Goldfarb J. Parvovirus B19 infections. Am Fam Physician. 1999; 60:1455-1460.
26. Palmer P, Pallier C, Leruez-Ville M, Deplanche M, Morinet F. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clin Diagn Lab Immunol. 1996;3:236-238.
27. Gray A, Guillou L, Zufferey J, et al. Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumors. J Gen Virol. 1998;79(pt 3):573-579.
28. Gentilomi G, Musiani M, Zerbini M, Gallinella G, Venturoli S, Manaresi E. Dot immunoperoxidase assay for detection of parvovirus B19 antigens in serum samples. J Clin Microbiol. 1997;35:1575-1578.
29. Pereira RF, Paula WN, Cubel Rde C, Nascimento JP. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Mem Inst Oswaldo Cruz. 2001;96:507-513.